APA (7th ed.) Citation

Q, L., J, S., Y, F., Z, Z., J, C., & C, Z. (2024). S100A8 is a prognostic signature and associated with immune response in diffuse large B-cell lymphoma. Frontiers in oncology, 14, 1344669. https://doi.org/10.3389/fonc.2024.1344669

Chicago Style (17th ed.) Citation

Q, Lin, Su J, Fang Y, Zhong Z, Chen J, and Zhang C. "S100A8 Is a Prognostic Signature and Associated with Immune Response in Diffuse Large B-cell Lymphoma." Frontiers in Oncology 14 (2024): 1344669. https://doi.org/10.3389/fonc.2024.1344669.

MLA (9th ed.) Citation

Q, Lin, et al. "S100A8 Is a Prognostic Signature and Associated with Immune Response in Diffuse Large B-cell Lymphoma." Frontiers in Oncology, vol. 14, 2024, p. 1344669, https://doi.org/10.3389/fonc.2024.1344669.